LARP6
La-related protein 6
Also known as: acheron, FLJ11196, LARP6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BRS8
- Gene
- LARP6
- Ensembl
- ENSG00000166173
- Chromosome
- 15
- Canonical length
- 491 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Microtubules,Cytokinetic bridge
OverviewNCBI Gene
Enables RNA binding activity and myosin binding activity. Involved in positive regulation of collagen biosynthetic process. Located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
491 residues, UniProt reviewed canonical sequence.
>Q9BRS8|LARP6
1 MAQSGGEARP GPKTAVQIRV AIQEAEDVDE LEDEEEGAET RGAGDPARYL SPGWGSASEE
61 EPSRGHSGTT ASGGENERED LEQEWKPPDE ELIKKLVDQI EFYFSDENLE KDAFLLKHVR
121 RNKLGYVSVK LLTSFKKVKH LTRDWRTTAH ALKYSVVLEL NEDHRKVRRT TPVPLFPNEN
181 LPSKMLLVYD LYLSPKLWAL ATPQKNGRVQ EKVMEHLLKL FGTFGVISSV RILKPGRELP
241 PDIRRISSRY SQVGTQECAI VEFEEVEAAI KAHEFMITES QGKENMKAVL IGMKPPKKKP
301 AKDKNHDEEP TASIHLNKSL NKRVEELQYM GDESSANSSS DPESNPTSPM AGRRHAATNK
361 LSPSGHQNLF LSPNASPCTS PWSSPLAQRK GVSRKSPLAE EGRLNCSTSP EIFRKCMDYS
421 SDSSVTPSGS PWVRRRRQAE MGTQEKSPGT SPLLSRKMQT ADGLPVGVLR LPRGPDNTRG
481 FHGHERSRAC VLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LARP6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 124 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 124 nTPM
- midbrain: 86 nTPM
- hippocampal formation: 83 nTPM
- basal ganglia: 81 nTPM
- amygdala: 57 nTPM
- hypothalamus: 53 nTPM
Single-cell type
- late primary spermatocytes: 481 nCPM
- early spermatids: 365 nCPM
- late spermatids: 328 nCPM
- epididymal principal cells: 231 nCPM
- oligodendrocytes: 142 nCPM
- epididymal efferent duct ciliated cells: 141 nCPM
Immune cell
- neutrophil: 0.3 nTPM
- basophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- white matter: 158 nTPM
- basal ganglia: 119 nTPM
- medulla oblongata: 98 nTPM
- cerebellum: 95 nTPM
- cerebral cortex: 94 nTPM
- midbrain: 94 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0.67
- gnomAD missense Z
- 1.51
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Lupus La protein
- La-type HTH domain
- Nucleotide-binding alpha-beta plait domain superfamily
- SUZ-C domain
- RNA-binding domain superfamily
- Winged helix-like DNA-binding domain superfamily
- Winged helix DNA-binding domain superfamily
- La domain containing protein
- La domain
- SUZ-C motif
- La-related protein 6, RNA recognition motif
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LARP6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LARP6 as an antibody target. Whether an autoantibody or antibody against LARP6 could matter depends on whether native LARP6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LARP6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LARP6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...